CDSCO

11 March 2025

CDSCO approved Durvalumab, cancer treatment of AstraZeneca

AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organisation, Directorate General of Health Services, Government of India to import for sale and distribution of Durvalumab solution for infusion 120 mg/2.4 ml and 500 mg/10 ml (Imfinzi) for an additional indication.

20 February 2025

Vacancy as Scientific Officer at Regional Drugs Testing Laboratory - Masters degree in Chemistry, Biochemistry, Pharmacy, Microbiology, Biotechnology

experience in Drugs Testing and Standardization and research; Masters degree in Chemistry or Biochemistry or Pharmacy or Pharmaceutical Chemistry or Pharmacology or Bacteriology or Medicine or Microbiology or Biotechnology from a recognized University or Institute. Filling up of one post of Scientific Officer Group A Gazetted, Non-Ministerial, in the Pay Level 10 Rs. 56,100 - 1,77,500 at Regional Drugs Testing Laboratory, RDTL, Guwahati.

10 February 2025

Opportunity to join Regional Drugs Testing Laboratory as Senior Scientific Officer, Salary up to 2 lakh month | M.Pharm, MSc Apply

Masters degree in Chemistry or Biochemistry or Pharmacy or Pharmaceutical Chemistry or Pharmacology or Bacteriology or Medicine or Microbiology or Biotechnology from a recognised university or institute.

7 February 2025

Vacancy for post of Deputy Director at Central Drugs Testing Laboratory

Masters degree in Chemistry or Biochemistry or Pharmacy or Pharmaceutical Chemistry or Pharmacology or Bacteriology or Medicine or Microbiology or Biotechnology from a recognised University or institute.

15 January 2025

Jobs as Junior Scientific Officer and Senior Scientific Assistant in Central Drugs Testing Laboratory, CDSCO

Filling up of one post of Senior Scientific Assistant Group B Gazetted, Non-Ministerial, in the Pay Level 7 Rs. 44900 - 142400 of pay matrix of 7th CPC in Central Drugs Testing Laboratory CDTL, Hyderabad, Central Drugs Standard Control Organisation, Directorate General of Health Services, Ministry of Health and Family Welfare on Deputation.

30 December 2024

Opening for Drugs Controller under Medical Devices Vertical in Central Drugs Standard Control Organisation | 14 vacancies

Bachelors degree in Bio Medical Engineering or Chemical Engineering or Bio-Technology or Mechanical Engineering or Electrical Engineering or Electronics Engineering or Instrumentation Engineering or Polymer Engineering or Computer Science Engineering or Medical Electronics Engineering or Pharmacy or Pharmaceutical Sciences or Microbiology or Bio-Chemistry or Chemistry or Life Sciences from a recognized University or Institute

4 October 2024

CDSCO under Ministry of Health & Family Welfare becomes Affiliate Member of the International Medical Device Regulators Forum

The Ministry of Health and Family Welfare has introduced comprehensive regulations for medical devices aimed at aligning the country's regulatory framework with globally accepted standards. This initiative seeks to foster a regulatory ecosystem that promotes growth and innovation in the medical device sector.

1 October 2024

Job as Senior Scientific Officer & Scientific Officer at Regional Drugs Testing Laboratory, CDSCO | Salary up to 2 lakh month

Masters degree in Pharmacy or Pharmaceutical Chemistry or Pharmacology or Chemistry or Biochemistry or Bacteriology or Medicine or Microbiology or Biotechnology; in the Regional Drugs Testing Laboratory, Guwahati, CDSCO, DGHS, Ministry of Health and Family Welfare.

27 September 2024

Torrent Pharma refutes claims of Shelcal 500 allegedly failing CDSCO quality test

Recent articles have been issued in media with reference to the Central Drugs Standard Control Organization East Zone, Kolkata report referring to one batch sample of Product Shelcal 500, amongst other drugs marketed by various pharmaceutical companies, allegedly being non-standard quality.

27 September 2024

Top brands of paracetamol, pantoprazole, amoxycilin amongst failed sample, says CDSCO

CDSCO reported top brands of paracetamol, pantoprazole, amoxicillin and other amongst failed samples reported by CDSCO. These samples are reported to be not of standard quality. Total 59 different brands from well known pharmaceutical industries failed to compile with standard quality.

Top brands like Clavam 625, Mexclav 625, Shelcal, Pan D failed various assays and quality tests, which were collected and tested by different Drugs Testing Laboratories.

Search

CDSCO approved Durvalumab, cancer treatment of AstraZeneca

RECOMMENDED POSTS

Subscribe with us

Jobs by Category